Unión Europea - español - EMA (European Medicines Agency)

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vacunas - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. el uso de esta vacuna debe estar en conformidad con las recomendaciones oficiales.

Chile - español - ISPC (Instituto de Salud Pública de Chile)

pfizer chile s.a. - tozinameran; famtozinameran - famtozinamerÁn (2) 5,00 mcg; tozinamerÁn (1) 5,00 mcg - inmunización activa para prevenir la enfermedad por coronavirus 2019 (covid 19) causada por el virus sars-cov-2, en personas de 5 años a 11 años de edad.

Chile - español - ISPC (Instituto de Salud Pública de Chile)

pfizer chile s.a. - tozinameran; famtozinameran - famtozinamerÁn (2) 15,00 mcg; tozinamerÁn (1) 15,00 mcg - inmunización activa con el fin de prevenir la covid-19 causada por el sars-cov-2, en individuos de 12 años y mayores.

Chile - español - ISPC (Instituto de Salud Pública de Chile)

pfizer chile s.a. - tozinameran - tozinamerÁn (1) 3,00 mcg - inmunización activa para prevenir la enfermedad por coronavirus 2019 (covid-19) causada por el virus sars-cov-2, en personas de 6 meses a 4 años de edad.

Unión Europea - español - EMA (European Medicines Agency)

hipra human health s.l. - sars-cov-2 virus recombinant spike (s) protein receptor binding domain (rbd) fusion heterodimer – b.1.351-b.1.1.7 strains - covid-19 virus infection - vacunas - bimervax is indicated as a booster for active immunisation to prevent covid-19 in individuals 16 years of age and older who have previously received a mrna covid-19 vaccine.

Unión Europea - español - EMA (European Medicines Agency)

sanofi pasteur - sars-cov-2 prefusion spike delta tm protein, recombinant (b.1.351 strain) - covid-19 virus infection - vacunas - vidprevtyn beta is indicated as a booster for active immunisation to prevent covid-19 in adults who have previously received an mrna or adenoviral vector covid-19 vaccine (see sections 4. 2 y 5. 1 in product information document). el uso de esta vacuna debe estar en conformidad con las recomendaciones oficiales.

Perú - español - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

laboratorio farmaceutico america s.r.ltda. - jarabe

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

laboratorios grifols, s.a. - glucosa monohidrato, l-triptofano, glicina, taurina, aceite soja purificado, isoleucina, leucina, valina, lisina hidrocloruro, metionina, fenilalanina, treonina, alanina, arginina, histidina, prolina, serina, cisteina hidrocloruro hidratado, aspartico acido, glutamico acido, tirosina - excipientes: glicerol,oleato de sodio,hidroxido de sodio (e-524) - soluciones i.v. - soluciones para nutrición parenteral - combinaciones

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

laboratorios grifols, s.a. - glucosa monohidrato, l-triptofano, glicina, taurina, aceite soja purificado, isoleucina, leucina, valina, lisina hidrocloruro, metionina, fenilalanina, treonina, alanina, arginina, histidina, prolina, serina, cisteina hidrocloruro hidratado, aspartico acido, glutamico acido, tirosina - excipientes: glicerol,oleato de sodio,hidroxido de sodio (e-524) - soluciones i.v. - soluciones para nutrición parenteral - combinaciones

Perú - español - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

fresenius kabi peru s.a. - droguerÍa - emulsion para perfusion - por gramo mg - - combinaciones